Form 8-K Shire plc For: Oct 23

Go back to Form 8-K Shire plc For: Oct 23

Shire plc (SHPG) CEO Ornskov will not comment on Radius Health (RDUS) speculation - Conf. Call

October 23, 2015 7:40 AM EDT

Shire plc (NASDAQ: SHPG) CEO Flemming Ornskov will not comment on Radius Health (Nasdaq: RDUS) speculation.

... More

Shire plc (SHPG) Tops Q3 EPS by 35c

October 23, 2015 7:18 AM EDT

Shire plc (NASDAQ: SHPG) reported Q3 EPS of $3.24, $0.35 better than the analyst estimate of $2.89. Revenue for the quarter came in at $1.58 billion versus the consensus estimate of $1.63 billion.

Flemming Ornskov, M.D. Chief Executive Officer, commented:

In the third quarter, Shire maintained momentum while advancing the pipeline and investing for the future. VYVANSE again performed strongly in the adult market and we continued to demonstrate leadership in rare diseases, with the growth of our HAE assets, CINRYZE and FIRAZYR, and the strong performance of the recently launched NPS products... More